Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece

Journal of Medical Microbiology

Volumn 55, Issue 8, 2006, Pages 1153-1156

  Christakis, G B ^a   Perlorentzou, S ^a   Alexaki, P ^a   Megalakaki, A ^a   Zarkadis, I K ^b  

^a METAXA CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; CYTARABINE; FLUDARABINE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 16S; TIMENTIN; TOBRAMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; CENTRAL VENOUS CATHETER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ROSEOMONAS MUCOSA; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BACTEREMIA; BASE SEQUENCE; CATHETERIZATION, CENTRAL VENOUS; CYTARABINE; HUMANS; LEUKEMIA, MYELOID; MALE; METHYLOBACTERIACEAE; MOLECULAR SEQUENCE DATA; NEUTROPENIA; PENICILLANIC ACID; PHYLOGENY; PIPERACILLIN; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; VIDARABINE;

EID: 33747063081     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46634-0     Document Type: Article

References (19)

1. Clinical and Laboratory Standards Institute (2006). Performance standards for antimicrobial susceptibility testing, sixteenth information supplement, M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute.
2. Cohen, M. F., Han, X. Y. & Mazzola, M. (2004). Molecular and physiological comparison of Azospirillum spp. isolated from Rhizoctonia solani mycelia, wheat rhizosphere, and human skin wounds. Can J Microbiol 50, 291-297.
3. Dé, I., Rolston, K. V. I. & Han, X. Y. (2004). Clinical significance of Roseomonas species isolated from catheter and blood samples: analysis of 36 cases in patients with cancer. Clin Infect Dis 38, 1579-1584.
4. Elshibly, S., Xu, J., McClurg, R. B., Rooney, P. J., Millar, B. C., Alexander, H. D., Kettle, P. & Moore, J. E. (2005). Central line-related bacteremia due to Roseomonas mucosa in a patient with diffuse large B-cell non-Hodgkin's lymphoma. Leuk Lymphoma 46, 611-614.
5. Greub, G., La Scola, B. & Raoult, D. (2004). Amoebae-resisting bacteria isolated from human nasal swabs by amoebal coculture. Emerg Infect Dis 10, 470-477.
6. Han, X. Y., Pham, A. S., Tarrand, J. J., Rolston, K. V., Helsel, L. O. & Levett, P. N. (2003). Bacteriologic characterization of 36 strains of Roseomonas species and proposal of Roseomonas mucosa sp. nov. and Roseomonas gilardii subsp. rosea subsp. nov. Am J Clin Pathol 120, 256-264.
7. Jiang, C.-Y., Dai, X., Wang, B.-J., Zhou, Y.-G. & Liu, S.-J. (2006). Roseomonas lacus sp. nov., isolated from freshwater lake sediment. Int J Syst Evol Microbiol 56, 25-28.
8. Kumar, S., Tamura, K. & Nei, M. (2004). MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5, 150-163.
9. Lewis, L., Stock, F., Williams, D., Weir, S. & Gill, V. J. (1997). Infections with Roseomonas gilardii and review of characteristics used for biochemical identification and molecular typing. Am J Clin Pathol 108, 210-216.
10. McLean, T. W., Rouster-Stevens, K., Woods, C. R. & Shetty, A. K. (2005). Catheter-related bacteremia due to Roseomonas species children with cancer. Pediatr Blood Cancer 44, 1-3.
11. Nahass, R. G., Wisneski, R., Herman, D. J., Hirsh, E. & Goldblatt, K. (1995). Vertebral osteomyelitis due to Roseomonas species: case report and review of the evaluation of vertebral osteomyelitis. Clin Infect Dis 21, 1474-1476.
12. Nolan, J. S. & Waites, K. B. (2005). Nosocomial ventriculitis due to Roseomonas gilardii complicating subarachnoid haemorrhage. J Infect 50, 244-251.
13. Rihs, J. D., Brenner, D. J., Weaver, R. E., Steigerwalt, A. G., Hollis, D. G. & Yu, V. L. (1993). Roseomonas, a new genus associated with bacteremia and other human infections. J Clin Microbiol 31, 3275-3283.
14. Sandoe, J. A. T., Malnick, H. & Loudon, K. W. (1997). A case of peritonitis caused by Roseomonas gilardii in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol 35, 2150-2152.
15. Schorch, P. E., Minniganti, V. R., Nair, R. & Cunha, B. A. (1999). Primary Roseomonas gilardii bacteremia in a patient with inflammatory breast cancer. Clin Microbiol Newsl 21, 188-190.
16. Struthers, M., Wong, J. & Janda, J. M. (1996). An initial appraisal of the clinical significance of Roseomonas species associated with human infections. Clin Infect Dis 23, 729-733.
17. Tabin, G., Danenhower, C., Reardon, D., Dimmig, J. & McCormick, G. (2001). Opportunistic Roseomonas keratitis. Cornea 20, 772-773.
18. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680.
19. Woo, P. C. Y., Leung, P. K. L., Leung, K. W. & Yuen, K. Y. (2000). Identification by 16S ribosomal RNA gene sequencing of an Enterobacteriaceae species from a bone marrow transplant recipient. Mol Pathol 53, 211-215.